Rubella Virus Vaccine: Recommendation on Immunization Practices: A Prelicensing Statement. Ann Intern Med. 1969;70:1239-1241. doi: 10.7326/0003-4819-70-6-1239
Download citation file:
Published: Ann Intern Med. 1969;70(6):1239-1241.
This content is PDF only. Please click on the PDF icon to access.
The live, attenuated rubella virus vaccine* soon to become available appears to be a highly effective immunizing agent and the first suitable method of controlling rubella.
Rubella is generally a mild illness, but if the infection is acquired by a woman in the early months of pregnancy it poses a direct hazard to the fetus. Preventing infection of the fetus is the principal objective of rubella control. This can best be achieved by eliminating the transmission of virus among children, who are the major source of infection for susceptible pregnant women. The live, attenuated rubella virus vaccine is safe and
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, Prevention/Screening, Vaccines/Immunization.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only